Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2589-2597

  Maeshima, Yohei ^a   Kashihara, Naoki ^a   Yasuda, Tatsuji ^a   Sugiyama, Hitoshi ^a   Sekikawa, Takashi ^a   Okamoto, Kazunori ^a   Kanao, Koichiro ^a   Watanabe, Yuzo ^b   Kanwar, Yashpal S ^c   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cationic liposomes; Glomerulonephritis; Kidney; Transcription factor; Transfection

Indexed keywords

OLIGODEOXYNUCLEOTIDE DERIVATIVE; TRANSCRIPTION FACTOR E2F;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE; CELL PROLIFERATION; COMPETITIVE INHIBITION; ELECTROPHORETIC MOBILITY; GENETIC TRANSFECTION; GLOMERULONEPHRITIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REGULATOR GENE;

EID: 0032103310     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI429     Document Type: Article

References (69)

1. Striker, L.J., E.P. Peten, S.J. Elliot, T. Doi, and G.E. Striker. 1991. Mesangial cell turnover: effect of heparin and peptide growth factors. Lab. Invest. 64:446-456.
2. Alpers, C.E., K.L. Hudkins, A.M. Gown, and R.J. Johnson. 1992. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney. Int. 41:1134-1142.
3. Klahr, S., G. Schreiner, and I. Ichikawa. 1988. The progression of renal disease. N. Engl. J. Med. 318:1657-1666.
4. Johnson, R.J., E. Raines, J. Floege, A. Yoshimura, P. Pritzl, C. Alpers, and R. Ross. 1992. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet derived growth factor. J. Exp. Med. 175:1413-1416.
5. Farnham, P.J., J.E. Slansky, and R. Kollmar. 1993. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta. 1155:125-131.
6. Nevins, J.R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:424-429.
7. Shan, B., C.Y. Chang, D. Jones, and W.H. Lee. 1994. The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol. Cell. Biol. 14:299-309.
8. Thalmeier, K., H. Synovsik, R. Mertz, E.L. Winnacker, and M. Lipp. 1989. Nuclear factor E2F mediates basic transcription and transactivation by E1a of the human MYC promoter. Genes Dev. 3:527-536.
9. Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO (Eur. Mol. Biol. Organ.) J. 11:1797-1804.
10. Yamaguchi, M., Y. Hayashi, F. Hirose, S. Matsuoka, K. Shiroki, and A. Matsukage. 1992. Activation of the mouse proliferating cell nuclear antigen gene promoter by adenovirus type 12 E1A proteins. Jpn. J. Cancer Res. 83:609-617.
11. Striker, G.E., and L.J. Striker. 1985. Glomerular cell culture. Lab. Invest. 53:122-131.
12. Sugiyama, H., N. Kashihara, H. Makino, Y. Yamasaki, and Z. Ota. 1996. Reactive oxygen species induce apoptosis in cultured human mesangial cells. J. Am. Soc. Nephrol. 7:2357-2363.
13. Sterzel, R.B., D.H. Lovett, H.G. Foellmer, M.C. Perfetto, D. Blemesdefer, and M. Kashgarian. 1986. Mesangial cell hillocks: nodular foci of exaggerated growth of cells and matrix in prolonged cultures. Am. J. Pathol. 125:130-140.
14. Davies, M. 1994. The mesangial cell: a tissue culture view. Kidney. Int. 45:320-327.
15. Maeshima, Y., N. Kashihara, H. Sugiyama, H. Makino, and Z. Ota. 1996. Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation. J. Am. Soc. Nephrol. 7:2219-2229.
16. Morita, H., K. Maeda, M. Obayashi, T. Shinzato, A. Nakayama, Y. Fujita, I. Takai, H. Kobayakawa, I. Inoue, S. Sugiyama, et al. 1992. Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy 1.1 antibody. Nephron. 60:92-99.
17. Yagi, K., H. Noda, H. Kurono, and N. Ohishi. 1993. Efficient gene transfer with less cytotoxicity by means of cationic liposomes. Biochem. Biophys. Res. Commun. 196:1042-1048.
18. Keane, W.F., and L. Raij. 1980. Impaired mesangial clearance of macromolecules in rats with chronic mesangial ferritin-antiferritin immune complex deposition. Lab. Invest. 43:500-508.
19. Sugiyama, H., N. Kashihara, H. Makino, Y. Yamasaki, and Z. Ota. 1996. Apoptosis in glomerular sclerosis. Kidney. Int. 49:103-111.
20. Johnson, R.J., R.L. Garcia, P. Pritzl, and C.E. Alpers. 1990. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am. J. Pathol. 136:369-374.
21. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:248-254.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thio-cyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
23. Onbe, T., N. Kashihara, Y. Yamasaki, H. Makino, and Z. Ota. 1994. Expression of mRNAs of cytokines and growth factors in the experimental glomerulonephritis. Res. Commun. Mol. Pathol. Pharmacol. 86:131-138.
24. Floege, J., E. Eng, B.A. Young, and R.J. Johnson. 1993. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney. Int. 43:S47-S54.
25. Abbot, F., J.J. Ryan, M. Ceska, K. Matsushima, C.E. Sarraf, and A.J. Rees. 1991. Interleukin-1β stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney. Int. 40:597-605.
26. Ruef, C., K. Budde, J. Lacy, W. Northemann, S. Baumann, B. Sterzel, and D.L. Coleman. 1990. Interleukin-6 is an autocrine growth factor for mesangial cells. Kidney. Int 38:249-257.
27. Schultz, P.J., P.E. Dicorleto, B.J. Silver, and H.E. Abboud. 1988. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am. J. Physiol. 255:F674-F684.
28. Floege, J., E. Eng, B.A. Young, C.E. Alpers, T.B. Barren, D.F. Bowen-Pope, and R.J. Johnson. 1993. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J. Clin. Invest. 92:2952-2962.
29. Kashihara, N., Y. Watanabe, H. Makino, and Y.S. Kanwar. 1992. Interleukin-1 induced alterations in glomerular proteoglycans: biochemical and tissue autoradiographic aspects. J. Am. Soc. Nephrol. 3:203-213.
30. Kashihara, N., Y. Watanabe, H. Makino, E.I. Wallner, and Y.S. Kanwar. 1992. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc. Natl. Acad. Sci USA. 89: 6309-6313.
31. Floege, J., E. Eng, V. Lindner, B.A. Young, M.A. Reidy, and R.J. Johnson. 1992. Rat glomerular mesangial cells synthesize basic FGF: release, upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis. J. Clin. Invest. 90:2362-2369.
32. Mackay, K., L.J. Striker, J.W. Stauffer, T. Doi, L.Y. Agodoa, and G.E. Striker. 1989. Transforming growth factor-β: murine glomerular receptors and responses to isolated glomerular cells. J. Clin. Invest. 83:1160-1167.
33. Iida, H., R. Seifert, C.E. Alpers, R.G.K. Gronwald, P.E. Phillips, P. Pritzl, K. Gordon, A.M. Gown, R. Ross, D.F. Bowen-Pope, and R.J. Johnson. 1991. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc. Natl. Acad. Sci. USA. 88: 6560-6564.
34. Border, W.A., S. Okuda, L.R. Languino, M.B. Sporn, and E. Ruoslahti. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature. 346:371-374.
35. Shin, S.H., Y. Fujiwara, T. Takama, S. Ochi, A. Wada, M. Fukunaga, Y. Orita, T. Kamada, and K. Tagawa. 1989. Analysis of inositol tris-and tetrakisphosphate in mesangial cells by HPLC. Kidney. Int. 35:1320-1323.
36. Force, T., J.M. Kyriakis, J. Avruch, and J. Bonventre. 1991. Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and independent pathways in glomerular mesangial cells. J. Biol. Chem. 266:6650-6656.
37. Kovesdi, I., R. Reichel, and J.R. Nevins. 1986. Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 45:219-228.
38. Yee, A.S., P. Raycaudhuri, L. Jakoi, and J.R. Nevins. 1989. The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding. Mol. Cell. Biol. 9:578-585.
39. Chittenden, T., D.M. Livingston, and W.G. Kaelin. 1992. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65:1073-1082.
40. Watson, R.J., P.J. Dyson, and J. McMahon. 1987. Multiple c-myb transcript cap sites are variously utilized in cells of mouse haemopoietic origin. EMBO (Eur. Mol. Biol. Organ.) J. 6:1643-1651.
41. Asano, M., J.R. Nevins, and R.P. Wharton. 1996. Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. Genes Dev. 10: 1422-1432.
42. DeGregori, J., G. Leone, K. Ohtani, A. Miron, and J.R. Nevins. 1995. E2F1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9:2873-2887.
43. Johnson, D.G., J.K. Schwarz, W.D. Cress, and J.R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 365:349-352.
44. Dobrowolski, S.F., D.W. Stacey, M.L. Harter, J.T. Steine, and S.W. Hiebert. 1994. An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene. 9:2605-2612.
45. Ishizaki, J., J.R. Nevins, and B.A. Sullenger. 1996. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat. Med. 2: 1386-1389.
46. Morishita, R., G.H. Gibbons, M. Horiuchi, K.E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, and V.J. Dzau. 1995. A gene therapy strategy using a transcriptional factor decoy of the E2F binding site inhibits smooth muscle cell proliferation in vivo. Proc. Natl. Acad. Sci. USA. 92:5855-5859.
47. Sullenger, B.A., H.F. Gallardo, G.E. Ungers, and E. Gilboa. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell. 63:601-608.
48. Bielinska, A., R.A. Shivdasani, L. Zhang, and G.J. Nabel. 1990. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science. 250:997-1000.
49. Woolf, T.M., D.A. Melton, and C.G.B. Jennings. 1992. Specificity of antisense oligo-nucleotides in vivo. Proc. Natl. Acad. Sci. USA. 89:7305-7309.
50. Prelich, G., C.K. Tan, M. Kostura, M.B. Mathews, A.G. So, K.M. Downey, and B. Stillman. 1992. Functional identity of proliferating cell nuclear antigen and a DNA polymerase β auxiliary protein. Nature. 326:517-520.
51. Bravo, R., R. Frank, P.A. Blundell, and B.H. Macdonald. 1987. Cyclin/ PCNA is the auxiliary protein of DNA polymerase d. Nature. 326:515-517.
52. Jaskulski, D., C. Gatti, S. Travali, B. Calabretta, and R. Baserga. 1988. Regulation of the proliferation cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J. Biol. Chem. 263:10175-10179.
53. Yamamoto, T., and C.B. Wilson. 1987. Quantitative and qualitative studies of antibody-induced mesangial damage in the rat. Kidney. Int. 32:514-525.
54. Baggchus, W.M., P.J. Hoedemaeker, J. Rozing, and W.W. Bakker. 1986. Glomerulo-nephritis induced by monoclonal anti-Thy 1.1 antibodies. Lab. Invest. 55:680-687.
55. Floege, J., R.J. Johnson, K. Gordon, H. Iida, P. Pritzl, A. Yoshimura, C. Campbell, C E. Alpers, and W.G. Couser. 1991. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney. Int. 40:477-488.
56. Kashihara, N., Y. Maeshima, H. Sugiyama, T. Sekikawa, K. Okamoto, Y. Morita, K. Kanao, Y. Yamasaki, H. Makino, Z. Ota, et al. 1995. Inhibition of mesangial cell proliferation and matrix expansion by antisense oligonucleotides. In Recent Advances in Molecular Nephrology. M. Arakawa and Y. Nakagawa, editors. KOHKO-DO/Niigata, Japan. 1-11.
57. Kashihara, N., Y. Maeshima, and H. Makino. 1997. Therapeutic intervention in glomerulonephritis by oligonucleotides. Exp. Nephrol. 5:126-131.
58. Weintraub, S.J., C.A. Prater, and D.C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:259-261.
59. Qin, X., D.M. Livingston, M. Ewen, W.R. Sellers, Z. Arany, and J.W.G. Kaelin. 1995. The transcription factor E2F-1 is a down stream target of RB action. Mol. Cell. Biol. 15:742-755.
60. Sellers, W., J. Rodgers, and W. Kaelin. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA. 92:11544-11548.
61. Ikeda, M., L. Jakoi, and J.R. Nevins. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA. 93:3215-3220.
62. Field, S.J., F.Y. Tsai, F. Kuo, A.M. Zubiaga, J.W.G. Kaelin, D.M. Livingston, S.H. Orkin, and M.E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 85:549-561.
63. Yamasaki, L., T. Jacks, R. Bronson, E. Goilot, E. Harlow, and N.J. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell. 85:537-548.
64. Ivey-Hoyle, M., R. Conroy, H.E. Huber, P.J. Goodhart, A. Oliff, and D.C. Heimbrook. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13: 7802-7812.
65. Lees, J.A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
66. Shan, B., X. Zhu, P.L. Chen, T. Durfee, Y. Yang, D. Sharp, and W.H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:5620-5631.
67. Helin, K., J.A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 70:337-350.
68. Kaelin, W.G.J., W. Krek, W.R. Sellers, J.A. DeCaprio, F. Ajchenbaum, C.S. Fuchs, T. Chittenden, Y. Li, P.J. Farnham, M.A. Blanar, et al. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 70:351-364.
69. Sardet, Y., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R.A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad Sci. USA. 92: 2403-2407.